La Jolla Pharmaceutical Company Present at Biotechnology Industry Organization (BIO) CEO Investor Conference

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq:LJPC) today announced that Deirdre Y. Gillespie, M.D., President and Chief Executive Officer, will present on Tuesday, February 12, at 12:30 pm Eastern Time during the BIO CEO Investor Conference. The conference will take place at The Waldorf=Astoria Hotel in New York City. An audio webcast of the presentation will be available through the Company’s Web site: http://www.ljpc.com.

MORE ON THIS TOPIC